CoChat

Steroidogenic Activity of StAR Requires Contact with Mitochondrial VDAC1 and Phosphate Carrier Protein

Open access
Bose, Mahuya, Whittal, Randy M., Miller, Walter L., Bose, Himangshu S. · 2008 · Journal of Biological Chemistry

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

The steroidogenic acute regulatory protein (StAR) is required for adrenal and gonadal steroidogenesis and for male sexual differentiation. StAR acts on the outer mitochondrial membrane (OMM) to facilitate movement of cholesterol from the OMM to the inner mitochondrial membrane to be converted to pregnenolone, the precursor of all steroid hormones. The mechanisms of the action of StAR remain unclear; the peripheral benzodiazepine receptor, an OMM protein, appears to be involved, but the identity of OMM proteins that interact with StAR remain unknown. Here we demonstrate that phosphorylated StAR interacts with voltage-dependent anion channel 1 (VDAC1) on the OMM, which then facilitates processing of the 37-kDa phospho-StAR to the 32-kDa intermediate. In the absence of VDAC1, phospho-StAR is degraded by cysteine proteases prior to mitochondrial import. Phosphorylation of StAR by protein kinase A requires phosphate carrier protein on the OMM, which appears to interact with StAR before it interacts with VDAC1. VDAC1 and phosphate carrier protein are the first OMM proteins shown to contact StAR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m709221200

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1. Identification of the interaction of VDAC1 with StAR on the OMM. A, simplified scheme of steroid hormone biosynthesis. B, disuccinimidyl suberate cross-linking (CR) of [35S]StAR synthesized in a cell-free transcription/translation system to OMM proteins on fresh mitochondria at 4 °C and at room temperature (R). A 75-kDa band (arrowhead) appeared with increased cross-linking time. C, mass spectrum (MS/MS) of the predominant VDAC1 peptide associated with the 75-kDa band. D, immunoprecipitation of cross-linked proteins with antisera to StAR, VDAC1, VDAC2, Tom40, and StAR preimmune serum. E, effect of VDAC1 knockdown on pregnenolone synthesis in COS-1 cells transfected with the indicated plasmids. There was no decrease in pregnenolone with nonspecific mixtures of siRNA (Neg). VDAC1 knockdown did not alter pregnenolone levels in cells treated with 22(R)-hydroxycholesterol. F, effect on steroidogenesis of blocking VDAC1 with KPA in COS-1 cells transfected with the indicated vectors. G, measurement of accumulated pregnenolone synthesis in COS-1 cells co-transfected with StAR/F2 in the presence of KPA, atractyloside, and bongkrekic acid. H, transient blocking of VDAC1 stops pregnenolone synthesis in MA-10 cell mitochondria incubated with biosynthetic StAR in the presence of KPA. Mitochondria previously treated with KPA were reisolated and reincubated with unlabeled cell-free synthesized StAR, then pregnenolone synthesis was determined. Data in panels E–H are mean ± S.E. of three separate experiments, each performed in triplicate.
FIGURE 1. Identification of the interaction of VDAC1 with StAR on the OMM. A, simplified scheme of steroid hormone biosynthesis. B, disuccinimidyl suberate cross-linking (CR) of [35S]StAR synthesized in a cell-free transcription/translation system to OMM proteins on fresh mitochondria at 4 °C and at room temperature (R). A 75-kDa band (arrowhead) appeared with increased cross-linking time. C, mass spectrum (MS/MS) of the predominant VDAC1 peptide associated with the 75-kDa band. D, immunoprecipitation of cross-linked proteins with antisera to StAR, VDAC1, VDAC2, Tom40, and StAR preimmune serum. E, effect of VDAC1 knockdown on pregnenolone synthesis in COS-1 cells transfected with the indicated plasmids. There was no decrease in pregnenolone with nonspecific mixtures of siRNA (Neg). VDAC1 knockdown did not alter pregnenolone levels in cells treated with 22(R)-hydroxycholesterol. F, effect on steroidogenesis of blocking VDAC1 with KPA in COS-1 cells transfected with the indicated vectors. G, measurement of accumulated pregnenolone synthesis in COS-1 cells co-transfected with StAR/F2 in the presence of KPA, atractyloside, and bongkrekic acid. H, transient blocking of VDAC1 stops pregnenolone synthesis in MA-10 cell mitochondria incubated with biosynthetic StAR in the presence of KPA. Mitochondria previously treated with KPA were reisolated and reincubated with unlabeled cell-free synthesized StAR, then pregnenolone synthesis was determined. Data in panels E–H are mean ± S.E. of three separate experiments, each performed in triplicate.CC BY-NC · PubMed Central
FIGURE 2. Role of VDAC1 in pregnenolone synthesis. A, Western blot of cytoplasm from VDAC1 knockdown COS-1 cells using the antisera indicated to the left. B, immunoprecipitation of StAR or phospho-StAR from VDAC1 knockdown COS-1 cells. C, COS-1 cells transfected with StAR were incubated with KPA, and lysates were immunoblotted with antisera to StAR and phospho-StAR. Blocking VDAC1 prevented processing of 32-kDa phospho-StAR to the 30-kDa form. D, pulse-chase experiments. COS-1 cells transfected with StAR were incubated in 30 mg/ml KPA, pulse labeled with [35S]methionine for 45 min, then chased with cold methionine for the indicated time and immunoprecipitated with the indicated antibodies. E, import kinetics of StAR. [35S]StAR was imported from 5 min to 2 h into COS-1 mitochondria (bottom) and compared with import into mitochondria from VDAC1 knockdown cells (top). F, activation of proteasomal proteases in the absence of VDAC1. Stably selected VDAC1 knockdown COS-1 cells were co-transfected with StAR and F2 and treated with the indicated protease inhibitors; StAR activity was restored by incubation with E64. G, immunoblotting of lysates from cells in panel F using antisera to StAR and phospho-StAR.
FIGURE 2. Role of VDAC1 in pregnenolone synthesis. A, Western blot of cytoplasm from VDAC1 knockdown COS-1 cells using the antisera indicated to the left. B, immunoprecipitation of StAR or phospho-StAR from VDAC1 knockdown COS-1 cells. C, COS-1 cells transfected with StAR were incubated with KPA, and lysates were immunoblotted with antisera to StAR and phospho-StAR. Blocking VDAC1 prevented processing of 32-kDa phospho-StAR to the 30-kDa form. D, pulse-chase experiments. COS-1 cells transfected with StAR were incubated in 30 mg/ml KPA, pulse labeled with [35S]methionine for 45 min, then chased with cold methionine for the indicated time and immunoprecipitated with the indicated antibodies. E, import kinetics of StAR. [35S]StAR was imported from 5 min to 2 h into COS-1 mitochondria (bottom) and compared with import into mitochondria from VDAC1 knockdown cells (top). F, activation of proteasomal proteases in the absence of VDAC1. Stably selected VDAC1 knockdown COS-1 cells were co-transfected with StAR and F2 and treated with the indicated protease inhibitors; StAR activity was restored by incubation with E64. G, immunoblotting of lysates from cells in panel F using antisera to StAR and phospho-StAR.CC BY-NC · PubMed Central
FIGURE 3. Characterization of phosphate carrier protein associated in the StAR complex. A, native gel electrophoresis of digitonin extract following import of [35S]StAR into isolated mitochondria. StAR, but not the inactive StAR mutant R182L, forms a 140-kDa complex, which is resistant to mild proteolysis with proteinase K (PK). Size markers are shown to the right. B, sucrose density gradient analysis of the 140-kDa complex. Size markers are shown to the left in all panels. Top panel, autoradiogram of gradient native-PAGE gel of sucrose gradient fractions. Second panel, SDS-PAGE gel of fractions from the same amount of protein displayed in the top panel subjected to mild proteolysis with PK. The purified complex from lanes 7 to 11 is resistant to proteolysis. Third to fifth panels, immunoprecipitation of the sucrose density gradient fractions with the indicated antibodies followed by SDS-PAGE. C, mass spectrometric identification of the predominant peptide, showing it is from PCP. D, antibody shifts of the digitonin extract of the 140-kDa complex. The digitonin-extracted complex was incubated with the indicated antibodies and analyzed by native gradient gel electrophoresis. E, immunoprecipitation. The digitonin-extracted 140-kDa complex was immunoprecipitated with the indicated antibodies and separated by SDS-PAGE.
FIGURE 3. Characterization of phosphate carrier protein associated in the StAR complex. A, native gel electrophoresis of digitonin extract following import of [35S]StAR into isolated mitochondria. StAR, but not the inactive StAR mutant R182L, forms a 140-kDa complex, which is resistant to mild proteolysis with proteinase K (PK). Size markers are shown to the right. B, sucrose density gradient analysis of the 140-kDa complex. Size markers are shown to the left in all panels. Top panel, autoradiogram of gradient native-PAGE gel of sucrose gradient fractions. Second panel, SDS-PAGE gel of fractions from the same amount of protein displayed in the top panel subjected to mild proteolysis with PK. The purified complex from lanes 7 to 11 is resistant to proteolysis. Third to fifth panels, immunoprecipitation of the sucrose density gradient fractions with the indicated antibodies followed by SDS-PAGE. C, mass spectrometric identification of the predominant peptide, showing it is from PCP. D, antibody shifts of the digitonin extract of the 140-kDa complex. The digitonin-extracted complex was incubated with the indicated antibodies and analyzed by native gradient gel electrophoresis. E, immunoprecipitation. The digitonin-extracted 140-kDa complex was immunoprecipitated with the indicated antibodies and separated by SDS-PAGE.CC BY-NC · PubMed Central
FIGURE 4. Role of phosphate carrier protein in pregnenolone synthesis. A, Western blot. Lysates collected from cells in panel B were immunoblotted with the indicated antibodies; ΔPCP denotes PCP knockdown by siRNA. B, pregnenolone synthesis by PCP knockdown COS-1 cells co-transfected with StAR and F2. Incubation with 22(R)-hydroxycholesterol served as a positive control. C, measurement of ATP in untreated VDAC1 knockdown or PCP knockdown COS-1 cells expressing StAR and F2, and in serum-starved COS-1 cells treated with 2-deoxyglucose or rotenone. D, measurement of pregnenolone synthesis in COS-1 cells transfected with StAR and F2 that were serum starved, then treated with 2-deoxyglucose or rotenone. PCP and VDAC1 knockdown cells served as negative controls, and F2-transfected cells treated with 22(R)-hydroxycholesterol served as a positive control. E, import of [35S]StAR after blocking ATP transport with mersalyl, PITC, or p-sulfo-PITC. The import of StAR was interrupted by blocking PCP with PITC; the addition of exogenous ATP restored StAR import in the presence of PITC. F,[35S]StAR was imported into isolated mitochondria in the presence and absence of mCCCP, bongkrekic acid, or atractylosidase. The intensity of the imported 30-kDa band was measured by phosphorimager and plotted against the concentrations of the drugs. Data in A, C, D, and F are expressed as mean ± S.E. of three separate experiments, each performed in triplicate.
FIGURE 4. Role of phosphate carrier protein in pregnenolone synthesis. A, Western blot. Lysates collected from cells in panel B were immunoblotted with the indicated antibodies; ΔPCP denotes PCP knockdown by siRNA. B, pregnenolone synthesis by PCP knockdown COS-1 cells co-transfected with StAR and F2. Incubation with 22(R)-hydroxycholesterol served as a positive control. C, measurement of ATP in untreated VDAC1 knockdown or PCP knockdown COS-1 cells expressing StAR and F2, and in serum-starved COS-1 cells treated with 2-deoxyglucose or rotenone. D, measurement of pregnenolone synthesis in COS-1 cells transfected with StAR and F2 that were serum starved, then treated with 2-deoxyglucose or rotenone. PCP and VDAC1 knockdown cells served as negative controls, and F2-transfected cells treated with 22(R)-hydroxycholesterol served as a positive control. E, import of [35S]StAR after blocking ATP transport with mersalyl, PITC, or p-sulfo-PITC. The import of StAR was interrupted by blocking PCP with PITC; the addition of exogenous ATP restored StAR import in the presence of PITC. F,[35S]StAR was imported into isolated mitochondria in the presence and absence of mCCCP, bongkrekic acid, or atractylosidase. The intensity of the imported 30-kDa band was measured by phosphorimager and plotted against the concentrations of the drugs. Data in A, C, D, and F are expressed as mean ± S.E. of three separate experiments, each performed in triplicate.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 5

  1. Stocco, 1996, Endocr. Rev., 17, 221
  2. Lingappa, 2005, Mount Sinai J. Med., 72, 141
  3. Masacardo, 1988, J. Pharmacol. Exp. Ther., 244, 361
  4. Genchi, 1988, Biochem. Biophys. Acta, 936, 413
  5. Doble, 1987, Mol. Pharmacol., 31, 42

Cited by

See all 143

Metadata

Authors
Bose, M., Whittal, R. M., Miller, W. L., & Bose, H. S.
Affiliations
  • University of Florida (US)
  • University of Alberta (CA)
  • University of California, San Francisco (US)
Corresponding author
Bose, Himangshu S.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2008-04
Volume
283
Issue
14
Pages
8837-8845
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2125415514
Cited by
143
References
42
Citations by year
2026: 2 · 2025: 12 · 2024: 6 · 2023: 8 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 4 · 2017: 7 · 2016: 13 · 2015: 6 · 2014: 12 · 2013: 12 · 2012: 11
FWCI
4.11
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • March of Dimes Foundation
  • American Heart Association
  • Pfizer
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-37922, R01DK037922)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
Keywords
steroidogenic acute regulatory protein, stars, VDAC1, mitochondrial outer membrane, steroidogenesis, cholesterol transport, protein phosphorylation, protein kinase A, protein degradation, mitochondrial protein import, translocator protein (TSPO), pregnenolone
MeSH terms
Steroidogenic Acute Regulatory Protein, Adrenal Glands, Animals, Chlorocebus aethiops, Cholesterol, Humans, Male, Mitochondria, Phosphoproteins, Phosphorylation, Pregnenolone, Protein Binding, Rabbits, Sheep, Testis, Cyclic AMP-Dependent Protein Kinases, COS Cells, Mitochondrial Proteins, Voltage-Dependent Anion Channel 1, Mitochondrial Membranes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.